A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Kari C. Nadeau, Terri Brown Whitehorn et al.|EClinicalMedicine|2019Cited by 132
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Sayantani Sindher et al.|New England Journal of Medicine|2023Cited by 129
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow’s Milk AllergyDaniel Petroni, Robert A. Wood, Philippe Bégin et al.|JAMA Pediatrics|2024Cited by 15
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Christian Vogelberg, Deborah Albright et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 14